CD8A and neoplasm: IL-27 is an immune regulatory cytokine that induces Th17 cells to produce IL-1025, 26, but it also exerts anti-tumor effects by enhancing survival of tumor-antigen-specific CD8+ T cells27 and suppressing Treg by blocking the expression of Foxp3 via STAT1 and STAT3 activation28, 29.